SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-064836
Filing Date
2024-05-24
Accepted
2024-05-24 19:46:59
Documents
1
Period of Report
2024-05-24

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3891
  Complete submission text file 0000950170-24-064836.txt   5347
Mailing Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472
Business Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472 617-952-0555
Werewolf Therapeutics, Inc. (Issuer) CIK: 0001785530 (see all company filings)

IRS No.: 823523180 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O EDITAS MEDICINE, INC. 1 MAIN STREET CAMBRIDGE MA 02142
Business Address
Chatterjee Meeta (Reporting) CIK: 0001835388 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40366 | Film No.: 24985994